Director/PDMR Shareholding

Allergy Therapeutics PLC
10 May 2006

Allergy Therapeutics plc

Director Shareholding

10 May 2006



Allergy Therapeutics plc ("the Company") announces that, on 8th May 2006, a US
Grantor Retained Annuity Trust (called the "Ignace Goethals GRAT 2001"), of
which Ignace Goethals was a Trustee, matured in favour of Mr. Goethals' three
children, each of whom is over 18. Mr. Goethals held 788,457 shares through this
vehicle since the Company's admission to AIM in 2004.


As a consequence, Mr. Goethals' ongoing beneficial holding of shares of 0.1pence
each in the Company, which include 719,349 shares held through another GRAT
(called "the Ignace Goethals GRAT 2003" which will mature in August 2008), is
1,797,912 shares.


There is no economic benefit accruing to Mr. Goethals as a result of the
maturity of the Ignace Goethals GRAT 2001.


                      This information is provided by RNS
            The company news service from the London Stock Exchange